Trillium Therapeutics Inc. (NASDAQ: TRIL) commenced a public offering of common share units of the Company and Series II Non-Voting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE